Chemotherapy with TS-1+CDDP Followed by Curative Operation for Locally Advanced Duodenal Cancer

A 53-year-old woman presented with back pain. She was admitted to hospital because a mass was detected in the right upper abdomen. Upper gastrointestinal endoscopy and hypotonic duodenography showed type 2 advanced cancer in the second portion of the duodenum. Computed tomography (CT) revealed a pri...

Full description

Saved in:
Bibliographic Details
Published inThe Japanese Journal of Gastroenterological Surgery Vol. 44; no. 7; pp. 836 - 841
Main Authors Yoshinaga, Keiji, Taketomi, Akinobu, Saeki, Hiroshi, Maehara, Yoshihiko, Morita, Masaru, Mima, Kosuke, Yoshida, Rintaro, Shirabe, Ken, Kakeji, Yoshihiro
Format Journal Article
LanguageJapanese
Published The Japanese Society of Gastroenterological Surgery 2011
Subjects
Online AccessGet full text
ISSN0386-9768
1348-9372
DOI10.5833/jjgs.44.836

Cover

More Information
Summary:A 53-year-old woman presented with back pain. She was admitted to hospital because a mass was detected in the right upper abdomen. Upper gastrointestinal endoscopy and hypotonic duodenography showed type 2 advanced cancer in the second portion of the duodenum. Computed tomography (CT) revealed a primary duodenal cancer with invasion to both the head of the pancreas and superior mesenteric vein. The patient was treated with combined chemotherapy using TS-1 and CDDP. TS-1 (80 mg/m2) was orally administered for 3 weeks (day 1-21), and CDDP (60 mg/m2) was simultaneously administered on day 8 every 5 weeks. The chemotherapeutic regimen was repeated for 3 cycles. CT after chemotherapy revealed the tumor to have decreased in size, while also showing an improvement of the pancreas and superior mesenteric vein invasion. The patient thereafter underwent a curative pancreaticoduodenectomy. The pathological grade was determined to be Grade 1b. The resection margins were negative (R0). The patient was doing well and showed no signs of any recurrence of the cancer at 12 months after the initiation of therapy. TS-1/CDDP combination chemotherapy was effective for locally advanced duodenal cancer.
ISSN:0386-9768
1348-9372
DOI:10.5833/jjgs.44.836